ESC Premium Access

Two-year outcomes of patients with atrial fibrillation treated with rivaroxaban: results from RIVER registry

Congress Presentation

About the speaker

Associate Professor Jan Beyer-Westendorf

Heart Centre Dresden - Dresden Technical University Hospital, Dresden (Germany)
5 presentations
0 follower

160 more presentations in this session

The impact of abnormal conduction zone on outcomes after catheter ablation for atrial fibrillation

Speaker: Associate Professor T. Mine (Hyogo, JP)

Thumbnail

Thromboembolic risk of movable type left atrial appendage thrombi in patients with atrial fibrillation under widespread use of anticoagulants

Speaker: Doctor M. Sugitani (Nishinomiya, JP)

Thumbnail

Rate and rhythm control treatment in the elderly and very elderly patients with atrial fibrillation: an observational cohort study of 1,497 patients

Speaker: Mr T. Klamer (Amsterdam, NL)

Thumbnail

One year outcome and analysis of peri-device leak of left atrial appendage occlusion devices

Speaker: Doctor M. Mansour (Montreal, CA)

Thumbnail

Risk prediction of atrial fibrillation and its complications in the community using high-sensitivity cardiac Troponin I: Results from the BiomarCaRE Consortium

Speaker: Doctor C. Boerschel (Hamburg, DE)

Thumbnail

Access the full session

Atrial fibrillation e-posters

Speakers: Associate Professor J. Beyer-Westendorf, Associate Professor T. Mine, Doctor M. Sugitani, Mr T. Klamer, Doctor M. Mansour...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: how to implement the guidelines and take-home message.

27 August 2021

ESC Premium Access

A patient with NSTEMI and atrial fibrillation: what do the guidelines say?

27 August 2021

ESC Premium Access

COVID-19 and ACS admissions: lessons from the UK.

27 August 2021

ESC 365 is supported by

logo Novo Nordisk